Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medtronic Announces Two New Trials To Expand TAVR Indications

Oct 19 2020

• By Reed Miller

Medtronic Evolut-PRO 29mm — Medtronic's Evolut PRO transcatheter aortic valve • Source: Medtronic

Related Content

AHA 2019: French Registry Data Favor Edwards’ Sapien TAVR Over Medtronic’s CoreValve

Nov 25 2019

FDA Expands TAVR Indication To Low-Risk Patients

Aug 16 2019

Medtronic Lays Out Plans To Achieve 5%+ Annual Growth

Oct 15 2020

Related Companies

Medtronic plc

Edwards Lifesciences Corp.

Additional Topics

Clinical Trials Research & Development Cardiovascular Cardiology Medical Device

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window